35 results
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
malignancy in 2026.
Corporate Updates
Strengthened Leadership Team with the addition of Diana Hausman, M.D. as Chief Medical Officer, and Kyle
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
. “Carrie built an incredibly talented team during her time with us. I would like to thank Carrie for her leadership and contributions to advancing
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
8 Jan 24
Regulation FD Disclosure
7:03am
royalties.
“Immunome’s leadership team’s track record of advancing paradigm-changing ADCs, along with Zentalis’ commitment to apply cutting-edge
8-K
EX-99.1
rx6cdbt
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
PRE 14A
cfjz4g 9waf23szgiz0
18 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
f967tkux puwjfx
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
y9ob6i
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
DEF 14A
hj1bmyx
23 Apr 21
Definitive proxy
4:05pm